Teresa Helsten
Overview
Explore the profile of Teresa Helsten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tai-Seale M, Baxter S, Vaida F, Walker A, Sitapati A, Osborne C, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e246565.
PMID: 38619840
Importance: Timely tests are warranted to assess the association between generative artificial intelligence (GenAI) use and physicians' work efforts. Objective: To investigate the association between GenAI-drafted replies for patient messages...
2.
Romero S, Au L, Flores-Ortega R, Helsten T, Palomino H, Kaiser B, et al.
Contemp Clin Trials
. 2024 Apr;
141:107537.
PMID: 38614445
Introduction: Children, adolescent, and young adult cancer survivors experience overall increased risks of infertility that are preventable through effective fertility preservation services prior to starting cancer treatment. Oncofertility care is...
3.
Shatsky R, Batra-Sharma H, Helsten T, Schwab R, Pittman E, Pu M, et al.
Breast Cancer Res
. 2024 Mar;
26(1):46.
PMID: 38481291
No abstract available.
4.
Shatsky R, Batra-Sharma H, Helsten T, Schwab R, Pittman E, Pu M, et al.
Breast Cancer Res
. 2024 Feb;
26(1):32.
PMID: 38408999
Background: Zilovertamab is a humanized monoclonal antibody targeting ROR1, an onco-embryonic antigen expressed by malignant cells of a variety of solid tumors, including breast cancer. A prior phase 1 study...
5.
Tai-Seale M, Baxter S, Millen M, Cheung M, Zisook S, Celebi J, et al.
J Am Med Inform Assoc
. 2023 Jul;
30(10):1665-1672.
PMID: 37475168
Objective: Physicians of all specialties experienced unprecedented stressors during the COVID-19 pandemic, exacerbating preexisting burnout. We examine burnout's association with perceived and actionable electronic health record (EHR) workload factors and...
6.
Nerb L, Yang E, Exume D, Dornisch A, Zhou B, Helsten T, et al.
J Adolesc Young Adult Oncol
. 2023 May;
12(6):843-850.
PMID: 37184539
Oncofertility counseling of female cancer patients lacks efficient access to tailored and valid infertility risk estimates to support shared decision-making on fertility preservation treatments. The objective was to develop, conduct...
7.
Yang E, Dornisch A, Nerb L, Helsten T, Kaiser B, Aristizabal P, et al.
J Adolesc Young Adult Oncol
. 2022 May;
12(2):241-249.
PMID: 35639102
Oncofertility care for pediatric, adolescent, and young adult cancer patients remains under-implemented across adult and pediatric oncology settings. We pilot tested an electronic health record (EHR)-enabled multicomponent oncofertility intervention (including...
8.
Tolaney S, Beeram M, Beck J, Conlin A, Dees E, Puhalla S, et al.
Front Oncol
. 2022 Feb;
11:810023.
PMID: 35223458
Background: Cyclin-dependent kinases (CDK) 4 and 6 regulate G1 to S cell cycle progression and are often altered in cancers. Abemaciclib is a selective inhibitor of CDK4 and CDK6 approved...
9.
Clark A, Yau C, Wolf D, Petricoin E, J van t Veer L, Yee D, et al.
Nat Commun
. 2021 Nov;
12(1):6428.
PMID: 34741023
HER2-targeted therapy dramatically improves outcomes in early breast cancer. Here we report the results of two HER2-targeted combinations in the neoadjuvant I-SPY2 phase 2 adaptive platform trial for early breast...
10.
Fraser Symmans W, Yau C, Chen Y, Balassanian R, Klein M, Pusztai L, et al.
JAMA Oncol
. 2021 Sep;
7(11):1654-1663.
PMID: 34529000
Importance: Residual cancer burden (RCB) distributions may improve the interpretation of efficacy in neoadjuvant breast cancer trials. Objective: To compare RCB distributions between randomized control and investigational treatments within subtypes...